In particular, the poor prognostic value of SOX11 expression in pancreatic cancer and sarcoma and SOX12 expression in breast and ovarian cancer as well as sarcoma, has not been reported previously (Figure 2, Figure 3 and Figure 4). Here, SOX12 is linked to ovarian carcinoma.